Ketorolac Tromethamine Injection shortage
Current 25 presentations · 7 manufacturers · first FDA posting 2018-03-23 · last update 2026-10-15
Manufacturers: Alembic Pharmaceuticals, Baxter Healthcare, Fresenius Kabi USA, LLC, Gland Pharma Limited, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Sagent Pharmaceuticals
Stated reasons (per FDA): Delay in shipping of the drug; Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) | Alembic Pharmaceuticals | Current Available |
— | Posted 03/23/2018 Updated 05/15/2026 | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) | Alembic Pharmaceuticals | Current Available |
— | Posted 03/23/2018 Updated 05/15/2026 | |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) | Alembic Pharmaceuticals | Current Available |
— | Posted 03/23/2018 Updated 05/15/2026 | |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) | Baxter Healthcare | Current Unavailable |
Demand increase for the drug | Estimated recovery: December 2026 | Posted 06/06/2018 Updated 10/02/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) | Baxter Healthcare | Current Available |
— | Posted 06/06/2018 Updated 10/02/2026 | |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release not available at this time. Check wholesalers for inventory. | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release not available at this time. Check wholesalers for inventory. | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Gland Pharma Limited | Current Available |
— | Posted 03/23/2018 Updated 07/22/2026 | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Gland Pharma Limited | Current Available |
Demand increase for the drug | Posted 03/23/2018 Updated 07/22/2026 | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Gland Pharma Limited | Current Available |
Demand increase for the drug | Posted 03/23/2018 Updated 07/22/2026 | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) | Gland Pharma Limited | Current Available |
Demand increase for the drug | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Posted 06/06/2018 Updated 07/22/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) | Gland Pharma Limited | Current Available |
Demand increase for the drug | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | Posted 06/06/2018 Updated 07/22/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 06/06/2018 Updated 10/14/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 06/06/2018 Updated 10/14/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted 06/06/2018 Updated 10/14/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: December 2027 | Posted 03/26/2018 Updated 10/08/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay | Posted 03/26/2018 Updated 10/08/2026 |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery; December 2027; Shortage per Manufacturer: Manufacturing Delay | Posted 03/26/2018 Updated 10/08/2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) | Sagent Pharmaceuticals | Current Limited Availability |
Delay in shipping of the drug | Estimated recovery: end-October to mid-November 2026 | Posted 03/26/2018 Updated 10/08/2026 |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) | Sagent Pharmaceuticals | Current Available |
— | Posted 03/26/2018 Updated 10/08/2026 | |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) | Sagent Pharmaceuticals | Current Available |
— | Posted 03/26/2018 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)